Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Health (social science)
Reference33 articles.
1. Bazo-Alvarez, J. C., Morris, T. P., Carpenter, J. R., Hayes, J. F., & Petersen, I. (2020). Effects of long-term antipsychotics treatment on body weight: A population-based cohort study. Journal of Psychopharmacology, 34(1), 79–85.
2. Centers for Medicare & Medicaid Services. Atypical Antipsychotic Medications: Use in Pediatric Patients. (2014). Retrieved June 15, 2019, from https://cms.gov/Medicare-Medicaid-Coordination/Fraud-Prevention/Medicaid-Integrity-Education/Pharmacy-Education-Materials/Downloads/atyp-antipsych-pediatric-factsheet11-14.pdf.
3. Citrome, L., & Volavka, J. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes: Response to consensus statement. Diabetes Care, 27(8), 2087–2088.
4. Connolly, J. G., Toomey, T. J., & Schneeweiss, M. C. (2015). Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003–2011. Psychiatric Services, 66(6), 604–609.
5. Correll, C. U., Manu, P., Olshanskiy, V., Napolitano, B., Kane, J. M., & Malhotra, A. K. (2009). Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA—Journal of the American Medical Association, 302(16), 1765–1773.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献